{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:24:57Z","timestamp":1761974697014,"version":"build-2065373602"},"reference-count":12,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1517\/14740338.2013.799664","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T09:41:23Z","timestamp":1369129283000},"page":"605-609","source":"Crossref","is-referenced-by-count":19,"title":["A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?"],"prefix":"10.1517","volume":"12","author":[{"given":"George J","family":"Kontoghiorghes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,5,21]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.6.3.235"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1080\/03630260802341703"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903496410"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80606-8"},{"key":"CIT0005","unstructured":"Exjade (deferasirox) tablets for oral suspension. Highlights of prescribing information. Novartis Pharmaceutical Corp, USA (T2011-106); 2011. p. 1-16"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-12-254532"},{"issue":"12","key":"CIT0007","first-page":"1","volume":"15","author":"Anonymous","year":"2010","journal-title":"ISMP Medicat Saf Alert"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2010.01499.x"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07970.x"},{"key":"CIT0013","first-page":"1187","volume":"91","author":"Tefler P","year":"2006","journal-title":"Haematologica"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12413"},{"key":"CIT0015","first-page":"CD007476","volume":"2","author":"Meerpohl JJ","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.2013.799664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T13:59:32Z","timestamp":1481637572000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.2013.799664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,21]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,21]]},"published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1517\/14740338.2013.799664"],"URL":"https:\/\/doi.org\/10.1517\/14740338.2013.799664","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2013,5,21]]}}}